Natural killer cells in antiviral defense: Function and regulation by innate cytokines

Annual Review of Immunology

Volumn 17, Issue , 1999, Pages 189-220

  Biron, Christine A ^a   Nguyen, Khuong B ^a   Pien, Gary C ^a   Cousens, Leslie P ^a   Salazar Mather, Thais P ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Chemokines; Interferons; Interleukin 12; Virus infections

Indexed keywords

CHEMOKINE; CYTOKINE; INTERFERON; INTERLEUKIN 12;

ANTIVIRAL ACTIVITY; CELL ACTIVATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CHEMOKINES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERFERONS; INTERLEUKIN-12; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; VIRUS DISEASES;

EID: 0033009888     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.17.1.189     Document Type: Review

References (253)

1. Trinchieri G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187-376
2. Biron CA. 1997. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:24-34
3. Unanue ER. 1997. Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance. Curr. Opin. Immunol. 9:35-43
4. Scharton-Kersten TM, Sher A. 1997. Role of natural killer cells in innate resistance to protozoan infections. Curr. Opin. Immunol. 9:44-51
5. Scott P, Trinchieri G. 1995. The role of natural killer cells in host-parasite interactions. Curr. Opin. Immunol. 7:34-40
6. Lanier LL, Spits H, Phillips JH. 1992.The developmental relationship between NK cells and T cells. Immunol. Today 13:392-95
7. Biron CA, van den Elsen P, Tutt MM, Medveczky P, Kumar V, Terhorst C. 1987. Murine natural killer cells stimulated in vivo do not express the T cell receptor α, β, T3δ, or T3ε genes. J. Immunol. 139:1704-10
8. Biron CA, Su HC, Orange JS. 1996. Function and regulation of natural killer (NK) cells during viral infections: characterization of responses in vivo. Methods: Companion Methods Enzymol. 9:379-93
9. Wang B, Biron C, She J, Higgins K, Sunshine M-J, Lacy E, Lonberg N, Terhorst C. 1994. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3ε gene. Proc. Natl. Acad. Sci. USA 91:9402-6
10. Trinchieri G, Santoli D, Koprowski H. 1978. Spontanteous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins. J. Immunol. 120: 1849-55
11. Santoli D, Trinchieri C, Koprowski H. 1978. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells. J. Immunol. 121:532-38
12. Gidlund M, Örn A, Wigzell H, Senik A, Gresser I. 1978. Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273:759-61
13. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G. 1991. Induction of interferon y production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869-79
14. Bancroft GJ, Schreiber RD, Unanue ER. 1991. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in seid mouse. Immunol. Rev. 124:5-24
15. + T cells upon NKR-P1 cross-linking, J. Exp. Med. 183:2391-96
16. Kim S, Yokoyama WM. 1998. NK cell granule exocytosis and cytokine production inhibited by Ly49A engagement. Cell. Immunol. 183:106-12
17. Warren HS, Kinnear BF, Phillips JH, Lanier LL. 1995. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J. Immunol. 154:5144-52
18. Biron CA, Gazzinelli RT. 1995. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr. Opin. Immunol. 7:485-96
19. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178:567-77
20. Wysocka M, Kubin M, Vieira LQ, Ozmen L, Garotta G, Scott P, Trinchieri G. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672-76
21. Ozmen L, Pericin M, Hakimi J, Chizzonite RA, Wysocka M, Trinchieri G, Gately M, Garotta G. 1994. Interleukin 12, interferon γ, and tumor necrosis factor α are key cytokines of the generalized Schwartzman reaction. J. Exp. Med. 180:907-15
22. Heremans H, Dillen C, van Damme J, Billiau 1994. Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice. Eur. J. Immunol. 24:1155-60
23. Bendelac A, Rivera MN, Park S-H, Roark JH. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535-62
24. + T cells: a new family of T cells. Immunol. Today 17:71-76
25. MacDonald HR. 1995. NK1.1+ T cell receptor-α/β+ cells: new clues to their origin, specificity, and function. J. Exp. Med. 182:633-38
26. Medzhitov R, Janeway CA. 1997. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9:4-9
27. Hsich CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. 1993. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-49
28. Manetti R, Parronchi P, Giudizi MG, Piccini MP, Maggi E, Trinchieri G, Romagnani S. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199-204
29. Wiltrout RH, Mathieson BJ, Talmadge JE, Reynolds CW, Zhang SR, Herberman RB, Ortaldo JR. 1984. Augmentation of organ-associated natural killer activity by biological response modifiers: isolation and characterization of large granular lymphocytes from the liver. J. Exp. Med. 160:1431-49
30. Wiltrout RH, Pilaro AM, Gruys ME, Talmadge JE, Longo DL, Ortaldo JR, Reynolds CW. 1989. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow. J. Immunol. 143:372-78
31. Salazar-Mather TP, Ishikawa R, Biron CA. 1996. Natural killer (NK) cell trafficking and cytokine expression in splenic compartments after interferon-induction and viral infection. J. Immunol. 157:3054-64
32. Salazar-Mather TP, Orange JS, Biron CA. 1998. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways. J. Exp. Med. 187:1-14
33. Biron CA, Habu S, Okumura K, Welsh RM. 1984. Lysis of uninfected and virus-infected cells in vivo: a rejection mechanism in addition to that mediated by natural killer cells. J. Virol. 50:698-707
34. Bogen SA, Fogelman I, Abbas AK. 1983. Analysis of IL-2, IL-4, and IFN-γ-producing cells in situ during immune responses to protein antigens. J. Immunol. 150:4197-205
35. Scharton-Kersten T, Scott P. 1995. The role of the innate immune response in Th1 cell development following Leishmania major infection. J. Leukocyte Biol. 57:515-22
36. Bigger JE, Thomas CA, Atherton SS, 1998. NK cell modulation of murine cytomegalovirus retinitis. J. Immunol. 160: 5826-31
37. Bluman EM, Bartynski KJ, Avalos BR, Caligiuri MA. 1996. Human natural killer cells produce abundant macrophage inflammatory protein-1α in response to monocyte-derived cytokines. J. Clin. Invest. 97:2722-27
38. Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, Moir S, Monaco J, Ehler L, Mizell S, Jackson R, Li Y, Romano JW, Fauci AS. 1998. Natural killer cells from Human Immunodeficiency Virus (HIV)-infectcd individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J. Clin. Invest. 102:223-31
39. Koo GC, Peppard JR. 1984. Establishment of monoclonal anti-NK1.1 antibody. Hybridoma 3:301-3
40. Ortaldo JR, Winkler-Pickett R, Mason AT, Mason LH. 1998. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells. J. Immunol. 160:1158-65
41. Robertson JM, Caligiuri MA, Manley TJ, Levine H, Ritz J. 1990. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. J. Immunol. 145:3194-201
42. Welsh RM. 1978. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. 1. Characterization of natural killer cell induction. J. Exp. Med. 148:163-81
43. Grundy (Chalmer) JE, Trapman J, Allan JE, Shellam GR, Melief CJM. 1982. Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. Infect. Immun. 37:143-50
44. Orange JS, Biron CA. 1996. Characterization of early IL-12, IFN-α/β, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746-56
45. Biron CA, Welsh RM. 1982. Blastogenesis of natural killer cells during viral infection in vivo. J. Immunol. 129:2788-95
46. Biron CA, Sonnenfeld G, Welsh RM. 1984. Interferon induces natural killer cell blastogenesis in vivo. J. Leukocyte Biol. 35:31-37
47. Biron CA, Turgiss LR, Welsh RM. 1983. Increase in NK cell number and turnover rate during acute viral infection. J. Immunol. 131:1539-45
48. Biron CA, Young HA, Kasaian MT. 1990. Interleukin 2-induced proliferation of murine natural killer cells in vivo. J. Exp. Med. 171:173-88
49. Kasaian MT, Biron CA. 1990. Cyclosporin A inhibition of interleukin 2 gene expression, but not natural killer cell proliferation, after interferon induction in vivo. J. Exp. Med. 171:745-62
50. Su HC, Orange JS, Fast LD, Chan AT, Simpson SJ, Terhorst C, Biron CA. 1994. IL-2-dependent NK cell responses discovered in virus-infected β 2-microglobulin-deficient mice. J. Immunol. 153:5674-81
51. Kasaian MT, Biron CA. 1989. The activation of IL-2 transcription in L3T4+ and Lyt-2+ lymphocytes during virus infection in vivo. J. Immunol. 142:1287-92
52. Kasaian MT, Biron CA. 1990. Effects of cyclosporin A on IL-2 production and lymphocyte proliferation during infection of mice with lymphocytic choriomeningitis virus. J. Immunol. 144:299-306
53. Orange JS, Wang B, Terhorst C, Biron CA. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045-56
54. Orange JS, Biron CA. 1996. An absolute and restricted requirement for IL-12 in natural killer cell interferon-γ production and antiviral defense: studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156:1138-42
55. Ohteki T, MacDonald HR. 1994. Major histocompatibility complex class I related molecules control the development of CD4+ and CD4 subsets of natural killer 1.1+ T cell receptor-α/β+ cells in the liver of mice. J. Exp. Med. 180:699-704
56. Lantz O, Bendelac A. 1994. An invariant T cell receptor α chain is used by a unique subset of major histocompatibilily complex class I-specific CD4+ and CD4-CD8 - T cells in mice and humans. J. Exp. Med. 180:1097-106
57. Taniguchi M, Koseko H, Tokuhisa T, Masuda K, Sato H, Kondo H, Kawano T, Cui J, Perkes A, Koyasu S, Makino Y. 1996. Essential requirement of an invariant Vα14 T cell antigen receptor expression in the development of natural killer T cells. Proc. Natl. Acad. Sci. USA 93:11025-28
58. Bendelac A. 1995. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182:2091-96
59. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, Brutkiewicz RR. 1995. CD1 recognition by mouse NK1+ T lymphocytes. Science 268:863 65
60. Bendelac A, Killeen N, Littman, DR, Schwartz RH. 1994. A subset of CD4+ thymocytes selected by MHC class I molecules. Science 263:1774-78
61. Murakami M, Paul WE. 1998. Age-dependent appearance of NK1.1 + T cells in the livers of β2-microglobulin knockout and SJL mice. J. Immunol. 160:2649-54
62. Chen YH, Chiu NM, Mandai M, Wang N, Wang CR. 1997. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 6:459-67
63. Koyasu S. 1994. CD3+CD16+NK1.1 + B220+ large granular lymphocytes arise from both αβTCR+CD4-CD8-and γ δ TCR+ CD4-CD8-cells. J. Exp. Med. 179:1957-72
64. pos T cells promptly produce IL-4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285-95
65. Chen H, Paul WE. 1997. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J. Immunol. 159:2240-44
66. Maher JK, Kronenberg M. 1997. The role of CD1 molecules in immune responses to infection. Curr. Opin. Immunol. 9:456-61
67. Su HC, Cousens LP, Fast LD, Slifka MK, Bungiro RD, Ahmed R, Biron CA. 1998. CD4+ and CD8+ T cell interactions in IFN-γ and IL-4 responses to viral infections: requirements for IL-2. J. Immunol. 160:5007-17
68. Castaño AR, Tangri S, Miller JE, Holcombe HR, Jackson MR, Huse WD, Kronenberg M, Peterson PA. 1995. Peptide binding and presentation by mouse CD1. Science 269:223-26
69. Makino M, Winkler DF, Wunderlich J, Hartley JW, Morse HC, Holmes KL. 1993. High expression of NK-1.1 antigen is induced by infection with murine AIDS virus. Immunology 80:319-25
70. Raska K Jr, Gallimore PH. 1982. An inverse relation of the oncogenic potential of adenovirus-transformed cells and their sensitivity to killing by syngeneic natural killer cells. Virology 123:8-18
71. Sheil JM, Gallimore PH, Zimmer SG, Sopori ML. 1984. Susceptibility of adenovirus-2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis, J. Immunol. 132:1578-82
72. Bukowski JF, Woda BA, Habu S, Okumura K, Welsh RM. 1983. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131:1531-38
73. Walker CM, Rawls WE, Rosenthal KL. 1984. Generation of memory cell-mediated immune responses after secondary infection of mice with pichinde virus. J. Immunol. 132:469-74
74. Welsh RM, Brubaker JO, Vargas-Cortes M, O'Donnell CL. 1991. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J. Exp. Med. 173:1053-63
75. Welsh RM, Dundon PL, Eynon EE, Brubaker JO, Koo GC, O'Donnell CL. 1990. Demonstration of the antiviral role of natural killer cells in vivo with a natural killer cell-specific monoclonal antibody (NK1.1). Nat. Immun. Cell Growth Regul. 9:112-20
76. Habu S, Akamatsu K, Tamaoki N, Okumura K. 1984. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice. J. Immunol. 133:2743-47
77. Ching C, Lopez C. 1979. Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody. Infect. Immun. 26:49-56
78. Biron CA, Byron KS, Sullivan JL. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731-35
79. Bancroft GJ, Shellam GR, Chalmer JE. 1981. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J. Immunol. 126:988-94
80. Bukowski JF, Woda BA, Welsh RM. 1984. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52:119-28
81. Scalzo AA, Fitzgerald NA, Wallace CR, Gibbons AE, Smart YC, Burton RC, Shellam GR. 1992. The effect of the Cmv-I resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J. Immunol. 149:581-89
82. Quinnan GV Jr, Kirmani N, Rook AH, Manischewitz JF, Jackson L, Moreschi G, Santos GW, Saral R, Burns WH. 1982. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N. Engl. J. Med. 307:7-13
83. Merino F, Henle W, Ramirez-Duque P. 1986. Chronic active Epstein-Barr virus infection in patients with Chediak-Higashi syndrome. J. Clin. Immunol. 6: 299-305
84. Joncas J, Monczak Y, Ghibu F, Alfieri C, Bonin A, Ahronheim G, Rivard G. 1989. Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection. J. Med. Virol. 28:110-17
85. Stein-Streilein J, Guffee J. 1986. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J. Immunol. 136:1435-41
86. Monteiro JM, Harvey C, Trinchieri G. 1998. Role of interleukin-12 in primary influenza virus infection. J. Virol. 72:4825-31
87. Ballas ZK, Turner JM, Turner DA, Goetzman EA, Kemp JD. 1990. A patient with simultaneous absence of "classical" natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1 + subset. J. Allergy Clin. Immunol. 85:453-59
88. Casali P, Oldstone MB. 1982. Mechanisms of killing of measles virus-infected cells by human lymphocytes: interferon-associated and unassociated cell-mediated cytotoxicity. Cell. Immunol. 70:330-44
89. Harfast B, Orvell C, Alsheikhly A, Andersson T, Perlmann P, Norrby E. 1980. The role of viral glycoproteins in mumps-virus-dependent lymphocyte-mediated cytotoxicity in vitro. Scand. J. Immunol. 11:391-400
90. Alsheikhly A, Orvell C, Harfast B, Andersson T, Perlmann P, Norrby E. 1983. Sendai virus induced cell mediated cytotoxicity in vitro. The role of viral glycoproteins in cell mediated cytotoxidty. Scand. J. Immunol. 17:129-38
91. Godeny EK, Gauntt CJ. 1986. Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. J. Immunol. 137:1695-702
92. Godeny EK, Gauntt CJ. 1987. Murine natural killer cells limit coxsackievirus B3 replication. J. Immunol. 139:913-18
93. Hassin D, Fixler R, Bank H, Klein AS, Hasin Y. 1985. Cytotoxic T lymphocytes and natural killer cell activity in the course of mengo virus infection of mice. Immunology 56:701-5
94. McFarland HI, Bigley NJ. 1989. Sex-dependent, early cytokine production by NK-like spleen cells following infection with the D variant of encephalomyocarditis virus (EMCV-D). Viral Immunol. 2: 205-14
95. White LL, Smith RA. 1990. D variant of encephalomyocarditis virus (EMCV-D)-induced diabetes following natural killer cell depletion in diabetes-resistant male C57BL/6J mice. Viral Immunol. 3:67-76
96. Paya CV, Patick AK, Leibson PJ, Rodriguez M. 1989. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J. Immunol. 143:95-102
97. Stitz L, Althage A, Henganner H, Zinkernagel R. 1985. Natural killer cells vs cytotoxic T cells in the peripheral blood of virus-infected mice. J. Immunol. 134:598-602
98. Jacoby RO, Bhatt PN, Brownstein DG. 1989. Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus. Arch. Virol. 108:49-58
99. Delano ML, Brownstein DG. 1995. Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. J. Virol. 69:5875-77
100. Ruscetti FW, Mikovits JA, Kalyanaraman VS, Overton R, Stevenson H, Stromberg K, Herberman RB, Farrar WL, Ortaldo JR. 1986. Analysis of effector mechanisms against HTLV-I-and HTLV-III/LAV-infected lymphoid cells. J. Immunol. 136:3619-24
101. Skowron G, Cole BF, Zheng D, Accetta G, Yen-Lieberman B. 1997. gp120-directed antibody-dependent cellular cytotoxicity as a major determinant of the rate of decline in CD4 percentage in HIV-1 disease. AIDS 11:1807-14
102. Bonavida B, Katz J, Gottlieb M. 1986. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2. J. Immunol. 137:1157-63
103. Katz JD, Mitsuyasu R, Gottlieb MS, Lebow LT, Bonavida B. 1987. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity. J. Immunol. 139:55-60
104. Minato N, Bloom BR, Jones C, Holland J, Reid LM. 1979. Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J. Exp. Med. 149:1117-33
105. Griffin DE, Hess JL. 1986. Cells with natural killer activity in the cerebrospinal fluid of normal mice and athymic nude mice with acute Sindbis virus encephalitis. J. Immunol. 136:1841-45
106. Hirsch RL. 1981. Natural killer cells appear to play no role in the recovery of mice from Sindbis virus infection. Immunology 43:81-89
107. Trgovcich J, Aronson JF, Johnston RE. 1996. Fatal Sindbis virus infection of neonatal mice in the absence of encephalitis. Virology 224:73-83
108. Campbell AE, Slater JS. 1994. Down-regulation of major histocompatibility complex class I synthesis by murine cytomegalovirus early gene expression. J. Virol. 68:1805-11
109. Del Val M, Hengel H, Häcker H, Hartlaub U, Ruppert T, Lucin P, Koszinowski UH. 1992. Cytornegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-golgi compartment. J. Exp. Med. 176:729-38
110. Hengel H, Koszinowski UH. 1997. Interference with antigen processing by viruses. Curr. Opin. Immunol. 9:470-77
111. Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411-15
112. Jones TR, Hanson LK, Sun L, Slater JS, Stenberg RM, Campbell AE. 1995. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompabitility complex class I heavy chains. J. Virol. 69:4830-41
113. Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769-79
114. Tay CH, Welsh RM. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:267-75
115. Ruzek MC, Miller AH, Opal SM, Pearce BD, Biron CA. 1997. Characterization of early cytokine responses and an IL-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J. Exp. Med. 185:1185-92
116. Biron CA, Orange JS. 1995. IL-12 in acute viral infectious disease. Res. Immunol. 146:590-600
117. Lucin P, Jonjic S, Messerle M, Polic B, Hengel H, Koszinowski UH. 1994. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-γ and tumour necrosis factor. J. Gen. Virol. 75:101-10
118. MacMicking J, Xie QW, Nathan C. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-50
119. Heise MT, Virgin HW IV. 1995. The T cell independent role of γ interferon and tumor necrosis factor a in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J. Virol. 69:904-9
120. Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, MacMicking JD. 1993. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261:1445-48
121. Reiss CS, Komatsu T. 1998. Does nitric oxide play a critical role in viral infections? J. Virol. 72:4547-51
122. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K. 1991. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:617-48
123. Berger EA. 1997. HIV entry and tropism: the chemokine receptor connection. AIDS 11:S3-S16
124. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. 1995. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-15
125. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. 1996. CC-CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-58
126. Moore JP, Trkola A, Dragic T. 1997. Coreceptors for HIV-1 entry. Curr. Opin. Immunol. 9:551-62
127. Zhang X, Sun S, Hwang I, Tough DF, Sprent J. 1998. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8:591-99
128. Scharton-Kersten T, Afonso LCC, Wysocka M, Trinchieri G, Scott P. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320-30
129. Tripp CS, Wolf SF, Unanue ER. 1993. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725-29
130. Gazzinelli RT, Hieny S, Wynn T, Wolf S, Sher A. 1993. IL-12 is required for the T-lymphocyte-independent induction of IFN-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115-19
131. Hunter CA, Subauste CS, Van Cleave VH, Remington JS. 1994. Production of γ interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor α. Infect. Immun. 62:2818-24
132. Hunter CA, Timans J, Pisacane P, Menon S, Cai G, Walker W, Aste-Amezaga M, Chizzonite R, Bazan JF, Kastelein RA. 1997. Comparison of the effects of interleukin-1α, interleukin-1β, and interferon-γ-inducing factor on the production of interferon-γ by natural killer. Eur. J. Immunol. 27:2787-92
133. Doherty TM, Seder RA, Sher A. 1996. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156:735-41
134. Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA. 1996. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4:329-36
135. Warren HS, Kinnear BF, Kastelein RL, Lanier LL. 1996. Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK cells. J. Immunol. 156:3254-59
136. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395-403
137. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, Caligiuri MA. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96:2578-82
138. Puzanov IJ, Bennett M, Kumar V. 1996. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J. Immunol. 157:4282-85
139. Williams NS, Moore TA, Schatzle JD, Puzanov IJ, Sivakumar PV, Zlotnik A, Bennett M, Kumar V. 1997. Generation of lytic natural killer 1.1+, Ly-49-cells from multipotential murine bone marrow progenitors in a stroma-frec culture: definition of cytokine requirements and developmental intermediates. J. Exp. Med. 186:1609-14
140. Williams NS, Klem J, Puzanov IJ, Sivakumar PV, Schatzle JD, Bennett M, Kumar V. 1998. Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems. Immunol. Rev. In press
141. dim) human NK cells. J. Immunol. 156:3254-59
142. Okamura H, Nagata K, Komatsu T, Tanimoto T, Nukata Y, Tanabe F, Akita K, Torigoe K, Okura T, Fukuda S, Kurimoto M. 1995. A novel costimulalory factor for γ interferon induction found in the livers of mice causes endotoxic shock. Infect. Immun. 63:3966-72
143. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto T, Okamura H, Nakanishi K, Akira S. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383-90
144. Nakamura K, Okamura H, Nagata K, Komatsu T, Tamura T. 1993. Purification of a factor which provides a costimulatory signal for γ interferon production. Infect. Immun. 61:64-70
145. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041-48
146. Snijders A, Hilkens CM, van der Pouw Kraan TC, Engel M, Aarden LA, Kapsenberg ML. 1996. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 sub-unit. J. Immunol. 156:1207-12
147. Rook AH, Kehrl JH, Wakefield LM, Roberts AB, Sporn MB, Burlington DB, Lane HC, Fauci AS. 1986. Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136:3916-20
148. - large granular lymphocyte functions: regulation of IL-2Rβ (p75) signal transduction. J. Immunol. 146:3791-98
149. Su HC, Leite-Morris KA, Braun L, Biron CA. 1991. A role for transforming growth factor-β1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus, J. Immunol. 147:2717-27
150. Bellone G, Aste-Amezaga M, Trinchieri G, Rodeck U. 1995. Regulation of NK cell functions by TGF-β1. J. Immunol. 155:1066-73
151. Maghazachi AA, Al-Aoukaty A, Schall TJ. 1994. C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. J. Immunol. 153:4969-77
152. Taub DD, Sayers TJ, Carter CRD, Ortaldo JR. 1995. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:3877-88
153. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B. 1996. Activation of NK cells by CC chemokines: chemotaxis, Ca+ mobilization, and enzyme release. J. Immunol. 156:322-27
154. Vilcek J, Sen GC. 1996. Interferons and other cytokines. In Fundamental Virology, ed. BN Fields, DM Knipe, PM Howley. 11:341-65. Philadelphia/New York: Lippincott-Raven. 1340 pp. 3rd ed.
155. Pfeffer LM, Dinarello CA, Herberman RB, Williams BR, Borden EC, Bordens R, Walter MR, Nagabhushan TL, Trotta PP, Pestka S. 1998. Biological properties of recombinant α-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58:2489-99
156. Cousens LP, Orange JS, Su HC, Biron CA. 1997. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA 94:634-39
157. McRac BL, Semnani RT, Hayes MP, van Seventer GA. 1998. Type 1 IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J. Immunol. 160:4298-304
158. Lindahl P, Gresser I, Leary P, Tovey M. 1976. Interferon treatment of mice. Enhanced expression of histocompatibility antigens on lymphoid cells. Proc. Natl. Acad. Sci. USA 73:1284-87
159. Dunnick JK, Galasso GJ. 1980. Update on clinical trials with exogenous interferon. J. Infect. Dis. 142:293-99
160. Gresser I, Guy-Grand D, Maury C, Maunoury MT. 1981. Interferon induces peripheral lymphadenopathy in mice. J. Immunol. 127:1569-75
161. Korngold R, Blank KJ, Murasko DM. 1983. Effect of interferon on thoracic duct lymphocyte output: induction with either polyJ:C or vaccinia virus. J. Immunol. 130:2236-40
162. Ishikawa R, Biron CA. 1993. IFN induction and associated changes in splenic leukocyte distribution. J. Immunol. 150: 3713-27
163. Tough DF, Borrow P, Sprent J. 1996. Induction of bystander T cell proliferation by viruses and type 1 interferon in vivo. Science 272:1947-50
164. Rogge L, Barberis-Maino, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825-31
165. Feldman SB, Ferraro M, Zheng H-M, Patel N, Gould-Fogerite S, Fitzgerald-Bocarsly P. 1994. Viral induction of low frequency interferon-α producing cells. Virology 201:1-7
166. Fitzgerald-Bocarsly P, Howell DM, Pettera L, Tehrani S, Lopez C. 1991. Immediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1-infected fibroblasts. J. Virol. 65:3151-60
167. Lebon P. 1985. Inhibition of herpes simplex virus type-1 induced interferon synthesis by monoclonal antibodies against viral glycoprotein D and by lysosomotropic drugs. J. Gen. Virol. 66:2781-86
168. Darnell JE Jr. 1997. STATS and gene regulation. Science 277:1630-35
169. Schindler C, Darnell JE Jr. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621-51
170. Darnell JE Jr. Kerr IM, Stark GR. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-21
171. Silvennoinen O, Ihle JN, Schlessinger J, Levy DE. 1993. Interferon-induced nuclear signaling by Jak protein tyrosine kinases. Nature 366:583-85
172. Shual K, Ziemiecki A, Wilks AF, Harpur AG, Sadowski HB, Oilman MZ, Darnell JE Jr. 1993. Polypeptide signaling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 366:580-83
173. Velazquez L, Fellous M, Stark GR, Pellegrini S. 1992. A protein tyrosinc kinase in the interferon α/β signaling pathway, Cell 70:313-22
174. Schindler C, Shuai K, Prezioso VR, Darnell JE Jr. 1992. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257:809-13
175. Shuai K, Schindler C, Prezioso VR, Darnell JE Jr. 1992. Activation of transcription by IFN-γ: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258:1808-12
176. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431-42
177. Durbin JE, Hackenmiller R, Simon MC. Levy DE. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443-50
178. Beadling C, Guschin D, Witthuhn BA, Ziemiecki A, Ihle JN, Kerr IM, Cantrell DA. 1994. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon α, hut not the T cell antigen receptor, in human T lymphocytes. EMBO J. 13:5605-15
179. Cho SS, Bacon CM, Sudarshan C, Rees RC, Finbloom D, Pine R, O'Shea JJ. 1996. Activation of STAT4 by IL-12 and IFN-α: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J. Immunol. 157:4781-89
180. Li X, Leung S, Qureshi S, Darnell JE Jr, Stark GR. 1996. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-α. J. Biol. Chem. 271:5790-94
181. Stancato LF, Sakatsume M, David M, Dent P, Dong F, Petricoin EF, Krolewski JJ, Silvennoinen O, Saharinen P, Pierce J, Marshall CJ, Sturgill T, Finbloom DS, Lamer AC. 1997. Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway. Mol. Cell Biol. 17:3833-40
182. David M, Petricoin E 3rd, Benjamin C, Pine R, Weber MJ, Larner AC. 1995. Requirement for MAP kinase (ERK2) activity in interferon α-and interferon β-stimulated gene expression through STAT proteins. Science 269:1721-23
183. Platanias LC, Sweet ME. 1994. Interferon α induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoictic cells. J. Biol. Chem. 269:3143-46
184. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR. 1997. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav protooncogene product. Nature 385:169-72
185. Duncan GS, Mittrucker H-W, Kagi D, Matsuyama T, Mak TW. 1996. The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J. Exp. Med. 184:2043 48
186. Coutelier JP, Van Broeck J, Wolf SF. 1995. Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 69:1955-58
187. Kanangat S, Thomas J, Gangappa S, Babu JS, Rouse BT. 1996. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. Implications in immunopathogenesis and protection. J. Immunol. 156:1110-16
188. Schijns VECJ, Wierda CMH, van Hoeij M, Horzinek MC. 1996. Exacerbated viral hepatitis in IFN-γ receptor-deficient mice is not suppressed by IL-12. J. Immunol. 157:815-21
189. Consens LP, Orange JS, Biron CA. 1995. Endogenous IL-2 contributes to T cell expansion and IFN-γ production during lymphocytic choriomeningitis virus infection. J. Immunol. 155:5690-99
190. Schijns VECJ, Haagmans BL, Wierda CMH, Kruithof B, Heijnen IAFM, Alber G, Horzinek MC. 1998. Mice lacking IL-12 develop polarized Th1 cells during viral infection. J. Immunol. 160:3958-64
191. Orange JS, Wolf SF, Biron CA. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1253-64
192. Orange JS, Salazar-Mather TP, Opal SM, Spencer RL, Miller AH, McEwen BS, Biron CA. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:901-14
193. Trinchieri G. 1995. Interleukin-12: a pro-inflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-76
194. Sousa CR, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, Germain RN, Sher A. 1997. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186:1819-29
195. Chua AO, Chizzonite R, Desai BB, Truitt TP, Nunes P, Minetti LJ, Warrier RR, Presky DH, Levine JF, Gately MK, Gubler U. 1994. Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J. Immunol. 153:128-36
196. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U. 1996. A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc. Natl. Arad. Sci. USA 93:14002-7
197. Szabo SJ, Dighe AS, Gubler U, Murphy KM. 1997. Regulation of the interleukin (IL)-12R β 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817-24
198. Gollob JA, Kawasaki H, Ritz J. 1997. Interferon-γ and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high-affinity interleukin-12 receptor expression. Eur. J. Immunol. 27:647-52
199. Bacon CM, McVicar DW, Ortaldo Jr. Rees RC, O'Shea JJ, Johnston JA. 1995. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J. Exp. Med. 181:399-404
200. Bacon CM, Petricoin EF 3rd, Ortaldo Jr, Rees RC, Lamer AC, Johnston JA, O'Shea JJ. 1995. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl. Acad. Sci. USA 92:7307-11
201. Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell JE Jr, Murphy KM. 1995. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J. Exp. Med. 181:1755-62
202. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld GC, IhIe JN. 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171-74
203. Kaplan MH, Sun YL, Hoey T, Grusby MJ. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174-77
204. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson D, Giri J. 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965-68
205. Giri JG, Kumaki M, Ahdieh M, Friend DJ, Loomis K, Shanebeck K, DuBose R, Cosman D, Park LS, Anderson DM. 1995. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J. 14:3654-63
206. Chae D-W, Nosaka Y, Strom TB, Maslinski W. 1996. Distribution of IL-15 receptor α-chains on human peripheral blood mononuclear cells and effect of immuno-suppressive drugs on receptor expression. J. Immunol. 157:2813-19
207. Bazan JF, Timans JC, Kastelein RA. 1996. A newly defined interleukin-1? Nature 379:591
208. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimoto M, Tanimoto T, Flavell RA, Sato V, Harding MW, Livingston DJ, Su MS-S. 1997. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science 275:206-9
209. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, Wong W, Kamen R, Tracey D, Allen H. 1997. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 386:619-23
210. Torigoe K, Ushio S, Okura T, Kobayashi S, Taniai M, Kunikata T, Murakami T, Osamu S, Kojima H, Fujii M, Ohta T, Ikeda M, Ikegami H, Kurimoto M. 1997. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 272:25737-42
211. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, Hartley SB, Menon S, Kastelein R, Bazan F, O'Garra A. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity 7:571-81
212. Pulliam L, Moore D, West DC. 1995. Human cytomegalovirus induces IL-6 and TNF α from macrophages and microglial cells: possible role in neurotoxicity. J. Neurovirol. 1:219-27
213. Gilles PN, Fey G, Chisari FV. 1992. Tumor necrosis factor a negatively regulates hepatitis B virus gene expression in transgenic mice. J. Virol. 66:3955-60
214. Trgovcich J, Ryman K, Extrom P, Eldridge JC, Aronson JF, Johnston RE. 1997. Sindbis virus infection of neonatal mice results in a severe stress response. Virology 227:234-38
215. Moskophidis D, Frei K, Lohler J, Fontana A, Zinkernagel RM. 1991. Production of random classes of immunoglobulins in brain tissue during persistent viral infection paralleled by secretion of interleukin-6 (IL-6) but not IL-4, IL-5, and γ interferon. J. Virol. 65:1364-69
216. Kanangat S, Babu JS, Knipe DM, Rouse BT. 1996. HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: selective upregulation of IL-6 gene expression. Virology 219:295-300
217. Atedzoe BN, Ahmad A, Menezes J. 1997. Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction. J. Immunol. 159:4966-72
218. Flamand L, Stefanescu I, Menezes J. 1996. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J. Clin. Invest. 97:1373-78
219. Sareneva T, Matikainen S, Kurimoto M, Julkunen I. 1998. Influenza A virus-induced IFN-α/β and IL-18 synergistically enhance IFN-γ gene expression in human T cells. J. Immunol. 160:6032-38
220. Mo XY, Sarawar SR, Doherty PC. 1995. Induction of cytokines in mice with parainfluenza pneumonia. J. Virol. 69:1288-91
221. Su HC, Ishikawa R, Biron CA. 1993. Transforming growth factor-β expression and natural killer cell responses during virus infection of normal, nude, and SCID mice. J. Immunol. 151:4874-90
222. Pilaro AM, Taub DD, McCormick KL, Williams HM, Sayers TJ, Fogler WE, Wiltrout RH. 1994. TNF-α is a principal cytokine involved in the recruitment of NK cells to liver parenchyma. J. Immunol. 153:333-42
223. Fogler WE, Volker K, McCormick KL, Watanabe M, Ortaldo Jr, Reynolds CW. 1996. NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J. Immunol. 156:4707-14
224. Orange JS, Salazar-Mather TP, Opal SM, Biron CA. 1997. Mechanisms for virus-induced liver disease: a TNF-mediated pathology independent of NK and T cells during murine cytomegalovirus infection. J. Virol. 71:9248-58
225. Allavena P, Paganin C, Zhou D, Bianchi G, Sozzani S, Mantovani A. 1994. Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood 84:2261-68
226. Allavena P, Giardina G, Bianchi G, Mantovani A. 1997. IL-15 is chemotactic for natural killer cells and stimulates their adhesion to vascular endothelium. J. Leukocyte Biol. 61:729-35
227. Lukacs NW, Stricter RM, Einer VM, Evanoff HL, Burdick M, Kunkel SL. 1994. Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1α during monocyte-endothelial cell interactions. Blood 83:1174-78
228. Farber JM. 1990. A macrophage mRNA selectively induced by γ-interferon encodes a member of the platelet factor 4 family of cytokines. Proc. Natl. Acad. Sci. USA 87:5238-42
229. Luster AD, Unkcless JC, Ravetch JV. 1985. γ-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315:672-76
230. Amichay D, Gazzinelli RT, Karupiah G, Moench TR, Sher A, Farber JM. 1996. Genes for chemokines mumig and crg-2 are induced in protozoan and viral infections in response in response to IFN-γ with patterns of tissue expression that suggest nonredundant roles in vivo. J. Immunol. 157:4511-57
231. Lane TL, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ. 1998. Dynamic regulation of a-and b-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyclinating disease. J. Immunol. 160:970-78
232. Asensio VC, Camphell IL. 1997. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J. Virol. 71:7832-40
233. Lanier LL. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359-93
234. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L. 1996. Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14:619-48
235. Yokoyama WM. 1998. Natural killer cell receptors. Curr. Opin. Immunol. 10:298-305
236. Long EO, Wagtmann N. 1997. Natural killer cell receptors. Curr. Opin. Immunol. 9:344-50
237. Vivier E, Daëron M. 1997. Immunoreceptor tyrosine-based inhibition motifs. Immunol. Today 18:286-91
238. Parham P, ed. 1997. NK cells, MHC class I antigens and missing self. Immunol. Rev. 155:1-221
239. Allison AC. 1974. Interactions of antibodies, complement components and various cell types in immunity against viruses and pyogenic bacteria. Transplant. Rev. 19:3-55
240. Lanier LL, Corliss BC, Wu J, Leong C, Philips JH. 1998. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391:703-7
241. Smith KM, Wu J, Bakker ABH, Phillips JH, Lanier LL. 1998. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161:7-10
242. Kärre K, Ljunggren HG, Piontek G, Kiessling R. 1986. Selective rejection of H-2 deficient lymphoma variants suggest alternative immune defense strategy. Nature 319:675-78
243. Braud VM. Allan SJ, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B, and C. Nature 391:795-99
244. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273-82
245. Farrell HE, Hally H, Lynch DM, Fleming P, Shellam GR, Scalzo AA, Davis-Poynter NJ. 1997. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386:510-14
246. Reyburn HT, Mandelboim O, Valès-Gomez M, Davis DM, Pazmani L, Strominger JL. 1997. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514-16
247. Scalzo AA, Lyons PA, Fitzgerald NA, Forbes CA, Yokoyama WM, Shellam GR. 1995. Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and musNKR-P1. Genomics 27:435-41
248. Ahmed R, Biron CA. 1999. Immunity to viruses. In Fundamental Immunology. ed. WE Paul. New York: Raven. In press. 4th ed.
249. Biron CA. 1998. Interfaces between innate and adaptive immunity: role of interferons in shaping immune responses to viral infections. Semin. Immunol. 10:In press
250. Kos FJ, Engleman EG. 1996. Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell. Immunol. 173:1-6
251. Wang B, Nguyen K, Zhang X, Stamm L, David J, Satoskar A, Biron C. 1998. Use of a novel natural killer cell deficiency mouse model to evaluate role for NK cells in shaping adoptive immune responses during parasitic and viral infections, FASEB J. 12:A904 (Abstr.)
252. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M. 1993. Immune response in mice that lack the interferon-γ receptor. Science 259:1742-45
253. Graham MB, Dalton DK, Giltinan D, Braciale VL, Stewart TA, Braciale TJ. 1993. Response to influenza infection in mice with a targeted disruption in the interferon γ gene. J. Exp. Med. 178:1725-32